A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients With Metastatic Renal Cell Carcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-0379
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)